{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/52271"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/52271","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Production of phosphorylated beta-catenin by protein semi-synthesis","abstract":"Beta-catenin, a transcription factor involved in the wingless-related integration site (WNT) signaling pathway, has been linked to many different cancers such clear cell renal carcinoma and colorectal cancer. Dysregulation of Beta-catenin/WNT signaling pathway leads to uncontrolled proliferation, differentiation, and inhibition of apoptosis. Given that beta-catenin serves a central role in WNT signaling pathway, it is subject to tight regulation including by post-translational modifications. Phosphorylation of beta-catenin in its N- terminal segment at Ser33 and Ser37 by glycogen synthase kinase 3 (GSK3) regulates its activity, localization, and stability by recruiting the beta-transducin repeat-containing protein (beta-TrCP) E3 ubiquitin ligase complex to ubiquitinate beta-catenin leading to its proteasomal destruction. Moreover, there are other phosphorylation sites in this segment and throughout beta-catenin that have not been fully characterized. Herein, we used expressed protein ligation to generate di-phosphorylated beta-catenin at Ser33 and Ser37 along with fusing a biotin ligase known as biotin-based identification interacting protein 2 (BioID2) to its C-terminus as a proof of concept to generate a new protein regent to discover and assess other protein binding partners.","abstract_html":"Beta-catenin, a transcription factor involved in the wingless-related integration site (WNT) signaling pathway, has been linked to many different cancers such clear cell renal carcinoma and colorectal cancer. Dysregulation of Beta-catenin/WNT signaling pathway leads to uncontrolled proliferation, differentiation, and inhibition of apoptosis. Given that beta-catenin serves a central role in WNT signaling pathway, it is subject to tight regulation including by post-translational modifications. Phosphorylation of beta-catenin in its N- terminal segment at Ser33 and Ser37 by glycogen synthase kinase 3 (GSK3) regulates its activity, localization, and stability by recruiting the beta-transducin repeat-containing protein (beta-TrCP) E3 ubiquitin ligase complex to ubiquitinate beta-catenin leading to its proteasomal destruction. Moreover, there are other phosphorylation sites in this segment and throughout beta-catenin that have not been fully characterized. Herein, we used expressed protein ligation to generate di-phosphorylated beta-catenin at Ser33 and Ser37 along with fusing a biotin ligase known as biotin-based identification interacting protein 2 (BioID2) to its C-terminus as a proof of concept to generate a new protein regent to discover and assess other protein binding partners.","abstract_has_math":false,"creators":["Craley, Hannah"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Dempsey, Daniel","Gerstenfeld, Louis"],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-19T02:42:12Z","subjects":["Biochemistry","Health sciences"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/52271","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/52271","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F52271","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Dempsey, Daniel","Gerstenfeld, Louis"]},{"key":"dc:creator","label":"Author","values":["Craley, Hannah"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-02-11T19:47:29Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2028-02-10T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-02-10T23:02:33Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biochemistry","Health sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/52271"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2025"]},{"key":"dc:description.abstract","label":"Abstract","values":["Beta-catenin, a transcription factor involved in the wingless-related integration site (WNT) signaling pathway, has been linked to many different cancers such clear cell renal carcinoma and colorectal cancer. Dysregulation of Beta-catenin/WNT signaling pathway leads to uncontrolled proliferation, differentiation, and inhibition of apoptosis. Given that beta-catenin serves a central role in WNT signaling pathway, it is subject to tight regulation including by post-translational modifications. Phosphorylation of beta-catenin in its N- terminal segment at Ser33 and Ser37 by glycogen synthase kinase 3 (GSK3) regulates its activity, localization, and stability by recruiting the beta-transducin repeat-containing protein (beta-TrCP) E3 ubiquitin ligase complex to ubiquitinate beta-catenin leading to its proteasomal destruction. Moreover, there are other phosphorylation sites in this segment and throughout beta-catenin that have not been fully characterized. Herein, we used expressed protein ligation to generate di-phosphorylated beta-catenin at Ser33 and Ser37 along with fusing a biotin ligase known as biotin-based identification interacting protein 2 (BioID2) to its C-terminus as a proof of concept to generate a new protein regent to discover and assess other protein binding partners."]},{"key":"dc:title","label":"Title","values":["Production of phosphorylated beta-catenin by protein semi-synthesis"]}]}],"canonical_facts":{"dc:contributor.advisor":["Dempsey, Daniel","Gerstenfeld, Louis"],"dc:creator":["Craley, Hannah"],"dc:date.accessioned":["2026-02-11T19:47:29Z"],"dc:date.embargo":["2028-02-10T00:00:00Z"],"dc:date.issued":["2025"],"dc:date.updated":["2026-02-10T23:02:33Z"],"dc:description":["2025"],"dc:description.abstract":["Beta-catenin, a transcription factor involved in the wingless-related integration site (WNT) signaling pathway, has been linked to many different cancers such clear cell renal carcinoma and colorectal cancer. Dysregulation of Beta-catenin/WNT signaling pathway leads to uncontrolled proliferation, differentiation, and inhibition of apoptosis. Given that beta-catenin serves a central role in WNT signaling pathway, it is subject to tight regulation including by post-translational modifications. Phosphorylation of beta-catenin in its N- terminal segment at Ser33 and Ser37 by glycogen synthase kinase 3 (GSK3) regulates its activity, localization, and stability by recruiting the beta-transducin repeat-containing protein (beta-TrCP) E3 ubiquitin ligase complex to ubiquitinate beta-catenin leading to its proteasomal destruction. Moreover, there are other phosphorylation sites in this segment and throughout beta-catenin that have not been fully characterized. Herein, we used expressed protein ligation to generate di-phosphorylated beta-catenin at Ser33 and Ser37 along with fusing a biotin ligase known as biotin-based identification interacting protein 2 (BioID2) to its C-terminus as a proof of concept to generate a new protein regent to discover and assess other protein binding partners."],"dc:identifier.uri":["https://hdl.handle.net/2144/52271"],"dc:language.iso":["en_US"],"dc:subject":["Biochemistry","Health sciences"],"dc:title":["Production of phosphorylated beta-catenin by protein semi-synthesis"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:42:12Z"}